ArticleMovement disorders : official journal of the Movement Disorder Society2022

LRRK2 PROTAC Degraders as a Potential Novel Targeting Strategy for Parkinson's Disease?

Alexander ZimprichPubMed ↗Publisher ↗

No numbers read from the abstract.